BD Kiestra
Device Infection Prevention And Management
General payments
$3,386
Research payments
$494,075
Through program year 2020, $3,386 in general payments and $494,075 in research payments were reported against BD Kiestra (Infection Prevention And Management).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
3 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2020 | Research | $22,923 | 2 |
| 2019 | General | $3,386 | 28 |
| 2019 | Research | $471,152 | 5 |
Breakdown
Each share is of general payments naming this product in 2019.
Each share is of general payments naming this product to practitioners with a specialty in 2019. Each practitioner is counted under their primary specialty.
Each share is of general payments naming this product in 2019 where a state was reported.
Records
28 general · 7 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.